Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 27, 2011

Primary Completion Date

December 29, 2016

Study Completion Date

December 29, 2016

Conditions

Multiple Myeloma

Interventions

DRUG

Ixazomib

Ixazomib capsules

DRUG

Melphalan

Melphalan tablets

DRUG

Prednisone

Prednisone tablets

Trial Locations (20)

Lebanon

Morgantown

Vancouver

Toronto

Québec

Brno

Prague

Badalona

Barcelona

Donostia / San Sebastian

Madrid

Salamanca

Seville

Bournemouth

Brighton

Cambridge

London

Nottingham

Oxford

Uxbridge